EPLAW PATENT BLOG

IT – Meda Pharma v. Alfa Wassermann

Posted: November 11th, 2014

Meda Pharma GmbH & Co. KG v. Alfa Wassermann spa, Giellepi Chemicals srl, Milan court of appeal, Italy, 10 July 2014 – 16 October 2014 This judgment has confirmed the one rendered in the first instance, dated 23 September 2010 – 17 December 2010,  which may be read here. Apart from procedural issues, this judgment […]

READ MORE

UK – HTC v Gemalto

Posted: November 3rd, 2014

HTC Corporation v Gemalto S.A., Court of Appeal, 22 October 2014, [2014] EWCA Civ 1335, Laws LJ, Floyd LJ, Vos LJ The Court of Appeal upheld the decision of Birss J that claim 3 of Gemalto’s patent (EP (UK) 0 932 865, relating to using a high level programming language with a smart card or […]

READ MORE

ES – MSD & Intervet v. Bayer / Ex Parte Interim Injunction

Posted: November 3rd, 2014

Merck Sharp & Dohme Animal Health, S.L & Intervet International, B.V. v. Bayer Hispania, S.L., Commercial Court No. 1 of Barcelona, Spain, 29 July 2014, Docket No. 727/2014. MSD companies Merck Sharp & Dohme Animal Health, S.L. (“MSD AH”) and Intervet International, B.V. (“Intervet”) have been awarded in Spain urgent and ex parte preliminary relief […]

READ MORE

NL – De Koning v. Levoplant

Posted: November 3rd, 2014

De Koning vs. Levoplant, District Court The Hague, the Netherlands, 10 October 2014, case no.: C/09/469076 KG ZA 14-792  Both De Koning and Levoplant engage in growing ornamental plants, in particular orchids. De Koning holds European Patent EP 2 070 407 (the “Patent”). The Patent relates to a ‘Method and tubular body for raising plants'. De […]

READ MORE

UK – Nampak v. Alpla

Posted: October 20th, 2014

Nampak Plastics Europe Limited v Alpla UK Limited, UK Court of Appeal, 9 October 2014 (Briggs LJ, Floyd LJ, Macur LJ), Case No. [2014] EWCA Civ 1293 In the past applications for summary judgment in UK patent cases have rarely met with success: the Court must adopt the role of the ordinary skilled person to […]

READ MORE

FR – Genentech v. Hoechst and Sanofi-Aventis Deutschland / Referral CJEU

Posted: October 17th, 2014

A 100 Million Euro question referred to the CJEU: can a licensee be forced to pay royalties when the patent is held invalid?, by Pierre Véron and Amandine Métier, Véron & Associés Genentech v. Hoechst and Sanofi‑Aventis Deutschland, cour d’appel de Paris, 23 September 2014, Docket № 12/21810 On 23 September 2014, the cour d’appel […]

READ MORE

ES – Cinfa & Actavis v. Boehringer / Telmisartan + HCTZ SPC / Invalidity Appeal

Posted: October 17th, 2014

Laboratorios Cinfa, S.A. & Actavis Group PTC EHF v. Boehringer Ingelheim Pharma GmbH & Co. KG, Court of Appeals (3rd Section) of Navarra, Spain, 20 May 2014, Docket No. 278/2012. In a Decision rendered on 20 May 2014, the Court of Appeals of Navarra confirmed the invalidity of Boehringer’s SPC for the combination product Telmisartan […]

READ MORE

UK – Teva v Leo Pharma

Posted: October 15th, 2014

Teva UK Ltd and Teva Pharmaceutical Industries Ltd v LEO Pharma A/S and LEO Laboratories Ltd (Third Party), Patents Court, 6 October 2014, [2014] EWHC 3096 (Pat), Birss J The Patents Court held two Leo Pharma patents concerning a treatment for psoriasis invalid on the ground of obviousness.  The case is of interest not only […]

READ MORE

NL – LEO v. Sandoz

Posted: October 15th, 2014

LEO Pharmaceutical ProductsLtd v. Sandoz B.V., Supreme Court of the Netherlands, The Hague, 3 October 2014, Case No. nr. 13/03763 The Dutch Supreme Court ruled that (contrary to LEO's arguments) in the problem solution approach, it is irrelevant whether the avergare man skilled in the art acknowledged the 'problem'. Decisive is whether having regard to […]

READ MORE

UK – Velocys Inc v CompactGTL Ltd

Posted: October 15th, 2014

Velocys Inc v CompactGTL Limited, UK Patents Court, 22 September 2014, [2014] EWHC 2951 (Pat) This case raises some unusual issues regarding patent amendment.  Velocys, an exclusive licensee, alleged infringement of two European patents, EP (UK) Nos. 1 206 508 and 1 206 509.  The patents were almost identical specifications but with different claims and […]

READ MORE